The Patent Finder

Askgene Pharma Inc.

Also on record
Records under this name other than the patents Askgene Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Askgene Pharma Inc.

PatentTitleStatus Expires Confidence
US 11,059,885Novel Angiopoietin 2, VEGF Dual Antagonists
In force
 · High confidence
In forceHigh confidence
US 12,043,662Novel Angiopoietin 2, VEGF Dual Antagonists
In force
 · High confidence
In forceHigh confidence
US 12,715,912Novel Angiopoietin 2, VEGF Dual Antagonists
In force
 · High confidence
In forceHigh confidence
US 10,654,922Novel Angiopoietin 2, VEGF Dual Antagonists
In force
 · High confidence
In forceHigh confidence
US 11,746,147Novel Angiopoietin 2, VEGF Dual Antagonists
In force
 · High confidence
In forceHigh confidence
US 12,312,413Novel Antibodies and Methods for Making and Using the Same
In force
 · Medium confidence
In forceMedium confidence
US 11,505,618Novel Antibodies and Methods for Making and Using the Same
In force
 · Medium confidence
In forceMedium confidence
US 10,287,336Novel Feline Erythropoietin Receptor Agonists
Lapsed on the fee record
Ended May 14, 2023 · High confidence
Lapsed on the fee recordEnded May 14, 2023High confidence
US 10,077,308PD-L1 Specific Monoclonal Antibodies for Disease Treatment and Diagnosis
Lapsed on the fee record
Ended Sep 18, 2022 · High confidence
Lapsed on the fee recordEnded Sep 18, 2022High confidence
14/941,529Fusion Proteins With Dual Receptor Agonist Activities
Abandoned
Abandoned May 30, 2018
AbandonedAbandoned May 30, 2018
10 of 27 records shown.
Pro members see all 27.
Pro members: see all 27 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited